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ABSTRACT
The unresponsive use of antibiotics led to the appearance of multiple drug-resistant bacteria strains. Studying the mechanism by which bacteria can 
resist antibiotics, the so called quorum sensing and biofilm formation, enabled the researchers to find bioactive compounds, derived from eukaryotes 
and prokaryotes. The disrupt of this mechanism is called quorum sensing inhibitors or quorum quenchers. This article provides an overview on the 
current research done on such bioactive compounds, the possible use of them as antibiotic alternatives, what are the advantage and disadvantages, 
the source from which it has been extracted, and how it may succeed to overcome bacterial resistance. The recommendation of researchers is to use 
some of these natural antimicrobial compounds combined to lower doses of antibiotics for treatment, the fastest way to limit the adverse effects of the 
exploitation of antibiotics and to avoid bacterial resistance.
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INTRODUCTION
The innovation of antibiotics solved many health problems to human 
beings and animals from plenty of life-terrifying diseases [1]. The 
excessive irresponsible use of antibiotics, for human and veterinary 
therapy, resulted in the appearance of several bacterial strains resistant 
to antibiotics [2]. Plenty of research work was done to find alternative 
approaches to control these resistant organisms and the high mortality 
caused by them [3]. It is worthy to mention that bacterial infections cause 
approximately 65% of the total sum of infectious diseases. Bacterial 
communities produce pheromones or autoinducers act as cell-to-cell 
signaling to monitor population density and to coordinate the activities 
of the population such as biofilm formation, virulence, multiplication, 
spore formation, and horizontal gene transfer. This process is called 
bacterial quorum sensing [4]. Inside the biofilm, bacteria are more 
resistant to antibiotics around 1000 times more than their planktonic 
ones [5,6]. Research work done to interfere biofilm formation has 
enabled us to identify some compounds derived from eukaryotes and 
prokaryotes with the ability to quench or inhibit the quorum sensing 
system, called as quorum quenchers (QQ) or quorum sensing inhibitors 
(QSIs) [7-9]. These compounds gave a chance to develop new drugs to 
kill pathogens [10,11]. The objective of this work is screening of some 
QSIs and their possible applications as antimicrobial agents aiming to 
overcome antibiotic resistance and prolong the effective life span of 
antibiotic.
DEVELOPMENT OF ANTIBIOTIC RESISTANCE AND HEALTH 
THREATS
The development of several drug-resistant pathogens was listed by the 
World Health Organization as one of the top threats to public health 
in the world [12]. It was anticipated to evolve the bacterial resistance 
to antibiotic within 50 years approximately after its first use [13]. 
Unexpectedly, resistance to some antibiotics such as tetracyclines 
started to develop within a year of its approval by drug FDA [14].
Methicillin was discovered in 1959 and introduced to treat penicillin-
resistant Staphylococcus aureus, and then, methicillin-resistant 
phenotype strains were isolated 2 years later [15]. Similarly, the 
aminoglycoside streptomycin, which inhibits bacterial protein synthesis 
was introduced for the treatment of tuberculosis in 1945, but the 
emergence of rRNA mutations conferring streptomycin resistance to 
Mycobacterium tuberculosis strains was soon reported in 1956 (Table 1).
MECHANISMS BY WHICH BACTERIA RESIST ANTIBIOTICS
Antibiotic resistance takes place in bacteria by either innate 
resistance [17] or acquired resistance through gene transfer from 
adjacent organism [18-20] or increased mutation rates [21-23] or 
adaptive environmentally induced resistance [24].
Bacterial enzymatic modification leads to inactivation of the antibiotic 
(this happens to streptomycin which is chemically modified and become 
no longer able to bind to the ribosome to block protein synthesis) [25-27]. 
Furthermore, bacteria carry out alteration of the antibiotic target by 
degrading enzyme (like beta-lactamase proteins, formed by bacteria, 
might cut beta-lactam ring of the penicillin atom) [28].
In the same time, bacteria can change its cell wall permeability to push 
the antibiotic outside the cell [29-31].
The infectious disease society of America highlighted S. aureus, 
Enterococcus faecium, Klebsiella pneumoniae, Pseudomonas aeruginosa, 
Acinetobacter baumannii, and Enterobacter (ESKAPE) as species 
capable of “escaping” the antibacterial action of antibiotics by the above-
mentioned mechanisms. These species constitute a new paradigm in 
virulence, transmission, and antimicrobial resistance [32].
QUORUM SENSING
It is the language by which bacterial cell-to-cell communication takes 
place. It connects different bacterial cells of the same or different species 
as well as bacteria and the eukaryotic host cell. With the increased 
bacterial cell number, the production of signals, called autoinducers, 
grows and reaches a threshold level, whereas a wide alteration in 
gene expression takes place including genes encoding for adhesins, 
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exopolysaccharides (a major component of the biofilms), and virulent 
factors production. This gives the bacteria a chance to achieve specific 
actions that occur only when living in a community not when has been 
sporadic so that quorum sensing controls production and development 
of biofilms, virulence factors, sporulation, bioluminescence, and 
conjugation [33].
Biofilm and virulence disruption agents are called QQ or QSIs. They are 
considered a feasible alternative to antibiotics [34].
Three approaches were investigated to inhibit microbial QS:
First, disruption of autoinducer synthesis; second, the inhibition of 
ligand/receptor interactions; and third, degradation of the autoinducer 
through enzymatic destruction [35].
ADDRESSING ANTIBIOTIC RESISTANCE
A combination of antimicrobials may give synergistic effect due to the 
diversity of mechanisms which is necessary to overcome recurrent 
bacterial communication and kill persisting cells [36]. These multidrug 
cocktails were not confined to antibiotics but extended to combinations 
of antibiotics with natural compounds that have the ability of QQ and 
act as non-antibiotic adjuvants.
This combination usage promotes the antimicrobial effect and prevents 
the bacterial resistance because the disruption of biofilm makes bacteria 
more disposed to even low doses of antibiotics [37]. The synergism 
between antibiotics and QSIs showed good results in regulating the 
resistant strains of Staphylococcus pathogenesis, where the bacterial 
sensitivity to the commercial antibiotics was elevated by RNAIII-
inhibiting peptide [38,39]. QSIs such as furanone c30, patulin, penicillic 
acid, and garlic extract have been reported to improve the sensitivity 
of P. aeruginosa to tobramycin and leukocyte phagocytosis [40,41]. 
Intensive research work was done to study such natural antimicrobial 
compounds that may be used as adjuvants to antibiotics.
SCREENING OF SOME NATURAL ANTIMICROBIAL AGENTS:
Enzymes
More than 2000 different enzymes are currently known. They are produced 
by pancreatic ribonuclease and regulated by hormone-sensitive lipase.
Enzymes were grouped into six classes known as oxidoreductase, 
transferases, hydrolases, lyases (synthases), isomerases, and ligases.
At present, there are several commercial hydrolase preparations, 
effective against microbial biofilm, such as Spezyme GA300, Pandion, 
Resinase A2X, and Paradigm. The substrates for the hydrolases are 
peptidoglycan, the cell wall component which is responsible for the 
bacterial cell wall rigidity. Degradation of the cell wall leads to cell 
lyses due to disturbed osmotic pressure inside the cell. Gram-negative 
bacteria are less sensitive to bacteriolytic enzymes than Gram-positive 
bacteria due to differences in the cell wall structure.
Proteases are protein hydrolyzing enzymes, out of which subtilisins 
that are used widely for the control of biofilm in industry [42]. 
Lysostaphin is a metalloendopeptidase hydrolyzing enzyme. It cleaves 
Staphylococci cell walls including methicillin-resistant S. aureus 
(MRSA) [43]. Administration of lysostaphin in combination with 
oxacillin or vancomycin enhanced the antimicrobial effect against 
MRSA [44].
Among the polysaccharide hydrolyzing enzymes; lysozymes, 
alginate lysases, Dispersin B and amylases were reported. Lysozyme 
immobilized in chitosan was effective in inhibiting food spoilage 
microorganisms [45].
Alpha-amylase hydrolyzes existing biofilms of S. aureus [46]. 
Combination of proteases and amylases was effective in removing a 
Pseudomonas fluorescens biofilm [47].
The peroxidases, such as lactoperoxidases and myeloperoxidases, 
use the H2O2 to oxidize halides (bromide, chlorine, and iodine) and 
isocyanate producing more potent antimicrobial compounds active 
against invading pathogens [48].
Antimicrobial Enzymes Derived from Bacteria
Quorum quenching enzymes that have an ability to degrade QS signal 
acylated homoserine lactone (AHL) autoinducers are AHL-lactonases, 
AHL-acylase, decarboxylases, and deaminase [9]. These enzymes 
were derived from different kinds of bacteria such as Actinobacteria, 
Rhodococcus, Arthrobacter, Streptomyces, Firmicutes, Bacillus, 
Oceanobacillus, Anabaena, Cyanobacteria, Proteobacteria, Alteromonas, 
Comamonas, Halomonas, Hyphomonas, P. aeruginosa, K. pneumoniae, 
Ralstonia, and Stappia [49-52]. The mentioned organisms have either 
AHL-acylase or -lactonase enzymes while Rhodococcus erythropolis 
might be the only organism which has both enzymes [53,54]. 
Interestingly, Bacillus thuringiensis does not produce the QS signal 
AHL but produce AHL-lactonase [55]. Microorganisms that produce 
bacteriolytic enzymes (e.g., streptomycetes) usually express a complex 
of several cell wall degrading enzymes with different specificities.
Lipase enzymes are considered an innovative and environmentally 
friendly approach for biofilm control due to their lytic and dispersal 
activities. Most of lipase enzymes used in industries are of microbial 
origin. It catalyzes the hydrolysis of esters for long chain aliphatic 
acids; several microorganisms produce lipases such as eukarya, fungi, 
actinomycetes, yeast, bacteria, and archaea. Bacterial lipases include 
Bacillus, Penicillium, Staphylococcus, Pseudomonas, and Aspergillus [56]. 
α-amylase, β-glucanase, lipase, and protease were examined to disrupt 
flow-generated biofilms of P. fluorescens. The four enzymes showed 
modest reduction of biofilm colony-forming units [57].
Antimicrobial Enzymes Derived from Bacteriophage
Bacteriophages are viruses that replicate inside infected bacteria and 
then secret endolysins, called lytic system, to weaken the bacterial cell 
wall resulting in bacterial lysis to come out and spread to infect other 
bacterial cells. Endolysins, such as glucosidase, endopeptidase, amidase, 
Table 1: History of The Development of Antibiotic Resistance [16]
Years Developed Showed bacterial resistance
Before 1935 Sulfonamides
1941–1945 Β-lactam (penicillin)-streptomycin Sulfonamides
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and transglycosylase, showed bacteriolytic activity against Listeria 
monocytogenes, Bacillus anthracis, Staphylococcus, and Clostridium 
butyricum [4]. Furthermore, they can clear some Gram-positive bacterial 
infections such as Enterococcus faecalis and Clostridium perfringens, [58]. 
The pairing of an antibiotic with a bacteriophage adjuvant is currently 
used and available in Georgia. Combination of ciprofloxacin and a 
lytic phage cocktail is currently produced, by PhagoBioDerm, in a 
biodegradable polymer matrix. Amidase PAL and endopeptidase Cpl1 
from phage Cpl1 are synergistically capable to control the systemic 
pneumococcal disease [59,60]. Endolysins separated from phage 
phi3626 can treat Clostridium contaminations [61]. The type PAL of 
endolysin can kill the Streptococcus Group A. The type LYSK endolysins 
kill Staphylococcus, especially methicillin safe S. aureus [62]. Endolysins 
PlyV12 demonstrates a decent lytic movement against vancomycin, safe 
E. faecium, Enterococci, and E. faecalis [63].
Antimicrobial Enzymes Derived from Animal
Quorum quenching enzymes have been isolated from animals such as 
rats, mice, and zebrafish.
Porcine kidney acylase I inactivated QS signals and prevented 
the formation of biofilm in Pseudomonas putida and Aeromonas 
hydrophila [64]. Mammalian paraoxonases have hydrolytic effect on 
esters and lactones [65]. Mammalian type of lactonases differs from 
that derived from bacteria as the first type needs calcium ion to be 
active [65]. Epithelial cells of human have the ability to inactivate the 
autoinducer, AHLs, synthesized by P. aeruginosa [66].
Foods such as chicken breast, turkey patties, beef steak, beef patties, 
and homemade cheeses revealed inhibition for the Gram-positive 
bacteria autoinducer (AI-2) activity by 84.4–99.8% [67]. These QSIs 
vary in their effect on the expression of virulence-related genes [68].
Pancreatic lipase enzymes catalyze fatty acid synthesis in bacteria; 
therefore, it can serve as a potential antibacterial agent that is effective 
against many bacterial strains [69]. Lactonase, AHL acylase, and 
oxidoreductases are from mammalian paraoxonase. They are QSIs and 
can modulate P. aeruginosa infection [70].
Antimicrobial Enzymes Derived from Plants
Laccases, are QSIs enzymes, have been found in plant extracts derived 
from fruit, flowers, leaves, and bark of Laurus nobilis, Combretum 
albiflorum, and Sonchus oleraceus [71,72]. Alliinase and thiol enzyme 
group separated from garlic and other medicinal plants act as 
QSIs [73,74], lactonase presents in clover, lotus, legumes, peas, yam 
beans, and alfalfa showed AHL degrading abilities [75,76]. Papaya 
(Carica papaya L.) is rich in cysteine protease enzyme which has a crucial 
role in many vital antimicrobial processes in living organisms [77].
Quorum Quenching Enzymes Derived from Marine Organisms
Algae like Laminaria digitata has bromoperoxidase enzyme that has 
QQ ability by oxidation process to AHL signal group (3OC6HSL) [78]. 
Delisea pulchra contain halogenated furanones which similar in shape 
to bacterial AHLs and can block the receptors (LuxR) and hinder QS 
process [79,80].
Alginate lyases are enzymes, found in algae, invertebrates, and 
marine microorganisms, used in combination with gentamicin to 
control P. aeruginosa in the respiratory tracts of patients with cystic 
fibrosis [81-83].
Antimicrobial Digestive Enzymes
Digestive enzymes supplemented to improve the feed efficiency ratio 
and stimulate the absorption of nutrients, also affect on the bacterial 
population in the alimentary tract [84]. Some of these enzymes such 
as carbohydrates and phytases were synthesized and are commercially 
sold as feed additives to monogastric animal [85]. These enzymes 
will affect on the nourishment of intestinal flora which will compete 
the other pathogenic or harmful types of bacteria [84]. Furthermore, 
when xylanase and lysozyme enzymes were added to broiler chicken 
diet, it minimized the gastrointestinal lesions of C. perfringens in the 
ilium [86,87].
In conclusion, combination of certain types of enzymes, polysaccharide-
degrading enzymes, DNases, proteases, and anti-quorum sensing 
enzymes, is required for successful control of microbial infection. 
Unfortunately, industrial enzyme production is somewhat expensive, 
especially for biomedical applications where pure enzymes are 
required [88].
ANTIMICROBIAL PEPTIDES (AMPs)
AMPs are found among all living organisms as a component of the innate 
immune response [90,89]. Most of the reported AMPs were of animal 
origin such as glycine/arginine-rich peptides, tachyplesin, brevinin 
peptides, and alpha- and beta-defensins [91]. In plants, few AMPs have 
been isolated from seeds, roots, stems, flowers, and leaves from various 
species and have demonstrated activities against different pathogens 
such as viruses, fungi, bacteria, protozoa, and parasites. Thionins, 
defensins, lipid transfer proteins, puroindolines, and snakins were 
different groups of AMPs reported in plants [92]. >880 different AMPs 
with the same biological activity to the naturally occurring AMPs have 
been designed and engineered from natural nucleic acid sequences [93] 
or selected from online combinatorial libraries [94].
Bacterial resistance against AMPs is apparently more difficult to be 
emerged in comparison with existing antibiotics as they have several 
targets and several modes of actions [95]. However, some bacteria 
developed resistance against human AMPs during evolution [96,97]. 
Hence, plant AMPs could be better than human ones because they 
rarely contact human pathogens to induce such resistance.
AMPs range from 4 to about 40 amino acids in length, engineered 
AMPs are identical to natural ones and all of them are hydrophobic 
and cationic in nature. It plays its role inducing changes in membrane 
permeabilization, destabilization, inhibition of macromolecules 
synthesis, intracellular translocation of the peptide, and inhibition 
of DNA/RNA/protein synthesis [98]. As polycationic peptides, AMPs 
interact electrostatically with negatively charged bacterial surface 
structures including lipoteichoic acids, and then, they interact with the 
lipid bilayers of the cytoplasmic membrane forming transmembrane 
pores and resulting in weakening of the membrane [99]. AMPs exert 
its effect on microbial plasma membranes, within few seconds of 
addition. Then after, within 1 h, bacterial membrane vesiculation, 
fragmentation release of DNA, cell aggregation, and destruction of cell 
morphology were noted. Thus, AMPs should rapidly pass through outer 
membrane thick proteoglycan layer of Gram-positive bacteria and the 
lipopolysaccharide layer of Gram-negative bacteria [100].
It is apparent not always biomembrane permeabilization is required for 
AMPs activity as it can translocate inside microbial membranes as well. 
This translocation results in membrane leakage and may occur at low 
concentrations of AMP before inducing permeabilization. For example, both 
the defensin cryptdin-4 of human and the AMP magainin 2 of frog translocate 
across bacterial cell wall bilayers within average 10 min [101,102].
AMPs Derived from Bacteria
The bacterial enzymes peptide synthetases produce the AMPs such as 
polymyxin, gramicidin, bacteriocin, and sugar peptide. The polypeptide 
polymexin is obtained from Bacillus polymyxa. It is effective against 
different pathogenic bacterial species such as P. aeruginosa, Salmonella, 
Escherichia coli, and K. pneumoniae. The polypeptide bacteriocin is 
effective against Gram-negative cocci and spirochetes. Bacteriocin 
has been used commercially as feed additive for animals combined 
with bacitracin methylene salicylic acid and zinc [103]. There are 
several products of bacteriocins such as nisin, fermenticin, subticin, 
plantacin, helveticin, lactacin, and sakacin that have antimicrobial 
effect against resistant pathogenic strains [104], bacteriocin can kill 
bacterial cell by interfering its protein metabolism on molecular bases. 
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Many bacteriocins are applied as bacteriostatic in food products [105] 
as it can inhibit foodborne pathogens such as Clostridium botulinum, 
S. aureus, Bacillus spp., L. monocytogenes, and E. faecalis [106,107].
AMPs derived from plants
Major AMPs reported in plants were 5–13 kDa. Such small AMPs were 
shown to demonstrate good antibacterial activity against some bacteria 
such as S. aureus, E. coli, K. pneumoniae, and P. aeruginosa. Plant AMPs 
like other AMPs have higher activity against Gram-positive than Gram-
negative bacteria [108-110]. Different kinds of antimicrobial substances 
were reported such as saponins [111], canavanine, and some important 
antifungal defensins [112]. Antimicrobial activity of AMPs obtained 
from wheat endosperm was reported against S. aureus and Micrococcus 
luteus [113]; other studies showed that extracts of AMPs from different 
germinating and ungerminated seeds of Pisum sativum, Punica 
granatum, Cocos nucifera L., and Phaseolus vulgaris showed broad 
spectrum of antibacterial activity against Micrococcus luteus, S. aureus, 
Staphylococcus epidermidis, Salmonella typhi, K. pneumoniae, E. coli, 
Proteus vulgaris, Pasteurella multocida, and P. aeruginosa [114].
AMPs derived from marine organism
Marine green growth is rich in peptides and high assorted proteins [115]. 
Crypteins, the recently produced peptides, have novel therapeutic 
effect [116,117]. Brown seaweed Saccharina longicruris is rich in 
AMPs (>10 kDa MW) resulting from trypsin enzymatic hydrolysis and 
extracted using HPLC. Other subfractions of peptide precursors were 
identified such as ubiquitin, leucine, and histone that play a part of the 
innate immune defense of the seaweed [118].
PLANT EXTRACT & ESSENTIAL OILS (EOS)
Plant materials, known as phytobiotics, have been introduced in 
animal nutrition as antioxidative, antimicrobial, anti-inflammatory, 
and antiparasitic factors [119,120]. The phytobiotic compounds were 
classified into phenolics/polyphenols, alkaloids, terpenoids/EOs, 
and lectins/polypeptides [121]. Plant extracts exert the antimicrobial 
effect at MIC 100~1000 µg/ml in vitro [122]. These phytobiotics have 
different modes of action against pathogens. First, tannins act by iron 
deprivation and enzymes interactions [123]. Second, cryptolepine 
may act as DNA intercalator and an inhibitor of topoisomerase 
enzyme [124]. Third, saponins act on the bacterial membrane by 
binding with sterols causing membrane damages and deformity of 
cells [125]. In the same time, some plant compounds act as QSI as 
their chemical structure is like those of AHL so it can bind its receptors 
(LuxR/LasR) [126]. Furthermore, degradation of AHL signal takes 
place under the effect of γ-aminobutyric acid which promotes the 
bacteriolytic enzyme, lactonase [127]. Flavonoids such as kaempferol, 
naringenin, quercetin, and apigenin work as QSIs by inhibition of 
the QS autoinducers, HAI-1 or AI-2, mediated bioluminescence in 
Vibrio harveyi [128]. Catechins produced by herbal plants like tea 
can stimulate AHL-lactonase and clear the plasmid of E. coli [129]. 
Furocoumarins and rosmarinic acid present in grapefruit juice and 
the roots of sweet basil corrupt the biofilm formation by E. coli and 
P. aeruginosa, respectively [130,131]. Thymol is currently used in 
combination with vancomycin and EDTA as antimicrobial [132]. 
Furthermore, the combined effect of the antibiotic, tobramycin, and 
some plant extracts (cinnamaldehyde and baicalin hydrate as QSI) was 
effective to clear the infected lungs with Burkholderia cenocepacia and 
P. aeruginosa [133-135]. The usage of EO to combat epidemic infection 
by multiresistant bacteria is promising. The EO of lemon, thyme white, 
cinnamon, and lemongrass showed high antibacterial effect against 
some problematic strains such as Streptococcus, MRSA, and Candida 
strains [136,137]. The synergistic effect between the EO and antibiotics 
was reported where Mentha piperita, Thymus vulgaris, and Rosmarinus 
officinalis oils when combined with ciprofloxacin showed more efficient 
antimicrobial effect [138]. Hydrophobicity of EOs is the main reason of 
increased bacterial cell permeability and consequent leakage of cell 
constituents [139]. followed by disturbance of vital functions such as 
nutrient processing, synthesis of structural macromolecules, secretion 
of many growth key enzymes and protein synthesis. EO disrupts and 
lowers the intracellular PH of bacteria and consequently impairs many 
crucial cellular processes such as DNA transcription, protein synthesis, 
and enzymatic activity [140]. Furthermore, the production of ATP in 
prokaryotes occurs both in the cell wall and in the cytosol by glycolysis. 
Hence, the alterations on intracellular and external ATP balance will be 
affected due to the action of the EO on the cell membrane [141].
The anti-QS activity of EOs or its components was reported as they 
affect on the autoinducer expression [142].
CONCLUSION & RECOMMENDATION
We have to put in mind that alternatives to antibiotics should be non-
toxic, easily excreted from the body and have low residues, not stimulate 
bacterial resistance, be stable and do not decompose inside GIT, do not 
cause environmental pollution, have good taste, and kill the pathogen 
without destroying the normal flora.
Actually, till present, there is no antibiotic alternative that meets all 
the above-mentioned criteria. All proteinaceous compounds, such 
as feed enzymes and AMPs that have been put into market as well 
as bacteriophage lysins, enzymatic biofilm inhibitors, and quorum 
quenching enzymes under development, are naturally unstable and 
easily degraded in the digestive tract. On the other hand, antibiotics 
can directly kill bacteria or inhibit with better antibacterial effect 
than all antibiotic replacements. Antibiotics are made by single and 
relatively pure active ingredient with consistency, high stability, and 
quality ensured by good manufacturing practice. However, researchers 
appreciate the combination of more than antimicrobial compound to 
avoid the development of bacterial resistance. Combination of biofilm 
inhibitors with antibiotics showed good results than when used 
sporadic. Hence, we have to put in mind that we have to use the natural 
antimicrobials to prevent than to cure disease or in combination to 
antibiotics as adjuvant to improve its function and waiting for updates 
from scientific research.
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